Cascade Bio Secures $6M to Scale Breakthrough Biocatalysts
DENVER–(BUSINESS WIRE)–Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturing. The funding includes a $2.8M seed round led by Endurance28 with participation from Stray…